Maggie is an editor for The American Journal of Managed Care® (AJMC®) and produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.
She has a BA in English from Penn State University. You can connect with Maggie on LinkedIn.
KCCQ-OS Better Able to Predict Changes in Health Status, Study Says
After a 12-month follow-up of patients in the CHAMP-HF registry, Kansas City Cardiomyopathy Questionnaire Overall Summary Score (KCCQ-OS) was shown to be more prognostically accurate compared with New York Heart Association functional class.
Review Recommends Guidelines for Patients With MS Taking Herbal Drugs, Supplements
With many patients with multiple sclerosis (MS) increasingly turning to herbal drugs and supplements to treat their disease, for which there is no cure, a recent review evaluated the safety of these alternative therapies.
Infection Risk, Medical Claims High Among Patients With Multiple Sclerosis
Patients with multiple sclerosis have high rates of urinary and kidney infections, inpatient hospitalizations, and outpatient hospital claims, according to recent results presented at the Americas Committee for Treatment and Research in Multiple Sclerosis annual meeting.
Lenacapavir Against HIV Demonstrates Ongoing Potential
The safety and effectiveness of the long-acting agent is backed by data from trials of the drug among treatment-experienced individuals living with HIV-1 whose viral load is on the rise due to other regimens failing. Investigation continues among these patients, as well as treatment-naive patients.
Genetic Predisposition for Elevated BMI May Increase Risk of MS, Depression
A causal relationship between major depressive disorder (MDD) and multiple sclerosis (MS), and vice versa, was not found in a recent Mendelian randomization study, while higher body mass index (BMI) was shown to increase the risk for both.
Patients With HFpEF Administered Sacubitril/Valsartan Gain Renal Benefits
Study results from Taiwan of patients with heart failure and comorbid chronic kidney disease show a drop in the risk of renal function decline among patients with heart failure with preserved ejection fraction (HFpEF) administered sacubitril/valsartan.
Mixed Improvements Seen Among Patients With MS Practicing Mindfulness
A systematic review and meta-analysis of studies of patients with multiple sclerosis (MS) found that mindfulness- and acceptance-based interventions did not have a significant effect on mindfulness among these patients.
Caring for the Whole Patient With Diabetes Drives ChristianaCare Pilot Success
Collaboration enabled ChristianaCare to significantly grow its population of patients with well-controlled disease, thanks to a diabetes control roadmap that ensured both physical and emotional health needs were met through interprofessional partnerships.
HIV Care Continuum Strained Under COVID-19 Pandemic
The substitution of telemedicine for many in-person HIV services during the COVID-19 pandemic has produced mixed results, with persons living with HIV increasingly lost to follow-up despite favorable views of this method of care delivery.
Varying Physical Activity for Patients With HFpEF Fails to Increase VO2 Levels
A comparison of patients with heart failure with preserved ejection fraction (HFpEF) randomized to 1 of 2 physical activities did not show a significant increase in peak oxygen consumption (VO2) vs guideline-based physical activity.
Researchers Highlight Need for Pediatric-Specific Treatment, Research for MS
Compared with adult-onset multiple sclerosis (MS), pediatric-onset MS has few treatments directed at the condition, specifically those that promote remyelination, enhance neuroprotection, and remediate cognitive deficits.
Study Investigates Types of Support Among Gay Men Living With, Without HIV
Georgetown investigators attempted to answer how type of supportive relationship may affect outcomes among gay men living with and without HIV, comparing results seen with primary and secondary relationships and having no support.
Cosela Approved for Protection Against Myelosuppression From SCLC Treatment
The cyclin-dependent kinase 4/6 inhibitor trilaciclib (Cosela) is the first in its class to receive FDA approval as a protective agent against bone marrow loss from treatment for small cell lung cancer (SCLC).
HIV Self-testing Skyrockets Among Transgender Individuals in New Study
Compared with being offered standard testing services, offers of initial and repeat self-testing led to a 3.5-fold greater uptake of testing for HIV among transgender individuals in a new study out of England and Wales.